Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
44 hedge funds and large institutions have $66.5M invested in Marrone Bio Innovations, Inc. in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 6 closing their positions.
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
2% less funds holding
Funds holding: 45 → 44 (-1)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
19% less capital invested
Capital invested by funds: $82.4M → $66.5M (-$15.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$203K |
| 2 |
SIM
Spark Investment Management
New York
|
+$98.7K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$75.8K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$69.8K |
| 5 |
State Street
Boston,
Massachusetts
|
+$50.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$120K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$80.2K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$74K |
| 4 |
Jane Street
New York
|
-$64K |
| 5 |
Barclays
London,
United Kingdom
|
-$37K |
MBII Hedge Fund Activity: Q4 2018 in Review
44 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2018, worth a combined $66.5M — down 19% from $82.4M a quarter earlier.
Fund positioning in MBII was balanced in Q4 2018: 6 funds opened new positions, 6 closed out, 9 added to existing stakes and 11 trimmed.
The largest buyer was Fairpointe Capital, opening a new position worth an estimated $203K. The largest seller was Goldman Sachs, exiting entirely with an estimated $120K sold.
- 44 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2018, down from 45 in Q3 2018.
- Funds reported $66.5M of Marrone Bio Innovations, Inc. stock for Q4 2018, down 19% quarter-over-quarter.
- 6 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2018 and 6 closed out, a net change of 0 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2018 was Fairpointe Capital, an estimated $203K added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2018 was Goldman Sachs, an estimated $120K sold.
Based on aggregated 13F filings for Q4 2018.